More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

Finally, in parallel with these approaches, there is a clear need to definitively establish the most common mechanisms of cervical spine fracture and spinal cord injury in rugby union in order to ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Spinal cord injuries (SCIs) can temporarily or permanently disrupt critical functions, from sensation to breathing, contributing to substantial patient morbidities that are often lifelong. Researchers ...

The paralysis must be from a cervical spinal cord injury, or ALS, a rare disease that causes nerve cells to stop working and muscles to become weak, leading to paralysis. Surgeons will implant the ...

Spinal cord injury (SCI) remains the most serious complication of repairing descending thoracic and thoracoabdominal aortic aneurysms, with endovascular ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...